Skip to content
PubMed This is a summary of 74 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 74 referenced papers

Top Authors

Christian Wolpert
Klinikum Ludwigsburg
Arthur A.M. Wilde
Amsterdam UMC Location University of Amsterdam
Ibrahim El‐Battrawy
St. Josef-Hospital
İbrahim Akın
Heidelberg University
Rainer Schimpf
Heidelberg University
Andrea Mazzanti
University of Pavia
Martin Borggrefe
German Centre for Cardiovascular Research
Xiaobo Zhou
Heidelberg University
Volker Liebe
Heidelberg University
Silvia Giuliana Priori
University of Pavia

Top Institutions

Ranked by publications Top 10 institutions
02

Klinikum Ludwigsburg

Ludwigsburg, Germany

9 papers
04

German Centre for Cardiovascular Research

Berlin, Germany

23 papers
06

St. Josef-Hospital

Bochum, Germany

14 papers

References

References (74)
  1. 1

    Usefulness of exercise test in the diagnosis of short QT syndrome.

    Giustetto C, Scrocco C, Schimpf R, et al.

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2015; (17(4)):628-34 doi:10.1093/europace/euu351.

    PMID: 25833882
  2. 2

    Genotype-dependent differences in age of manifestation and arrhythmia complications in short QT syndrome.

    Harrell DT, Ashihara T, Ishikawa T, et al.

    International journal of cardiology 2015; (190()):393-402.

    PMID: 25974115
  3. 3

    A new KCNQ1 mutation at the S5 segment that impairs its association with KCNE1 is responsible for short QT syndrome.

    Moreno C, Oliveras A, de la Cruz A, et al.

    Cardiovascular research 2015; (107(4)):613-23 doi:10.1093/cvr/cvv196.

    PMID: 26168993
  4. 4

    [Brugada ECG].

    Richter S

    Herzschrittmachertherapie & Elektrophysiologie 2015; (26(3)):247-59 doi:10.1007/s00399-015-0391-5.

    PMID: 26249049
  5. 5

    Sinus bradycardia, junctional rhythm, and low-rate atrial fibrillation in Short QT syndrome during 20 years of follow-up: three faces of the same genetic problem.

    Righi D, Silvetti MS, Drago F

    Cardiology in the young 2016; (26(3)):589-92 doi:10.1017/S1047951115001432.

    PMID: 26279191
  6. 6

    Characterization of a Chinese KCNQ1 mutation (R259H) that shortens repolarization and causes short QT syndrome 2.

    Wu ZJ, Huang Y, Fu YC, et al.

    Journal of geriatric cardiology : JGC 2015; (12(4)):394-401 doi:10.11909/j.issn.1671-5411.2015.04.002.

    PMID: 26346102
  7. 7

    The prevalence and significance of a short QT interval in 18,825 low-risk individuals including athletes.

    Dhutia H, Malhotra A, Parpia S, et al.

    British journal of sports medicine 2016; (50(2)):124-9 doi:10.1136/bjsports-2015-094827.

    PMID: 26400956
  8. 8

    Influence of Gender on the Tolerability, Safety, and Efficacy of Quinidine Used for Treatment of Supraventricular and Ventricular Arrhythmias.

    Higgins AY, Waks JW, Josephson ME

    The American journal of cardiology 2015; (116(12)):1845-51.

    PMID: 26514302
  9. 9

    Genetic testing and genetic counseling in patients with sudden death risk due to heritable arrhythmias.

    Spoonamore KG, Ware SM

    Heart rhythm 2016; (13(3)):789-97.

    PMID: 26582592
  10. 10

    Early repolarization pattern: a marker of increased risk in patients with catecholaminergic polymorphic ventricular tachycardia.

    Tülümen E, Schulze-Bahr E, Zumhagen S, et al.

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2016; (18(10)):1587-1592 doi:10.1093/europace/euv357.

    PMID: 26705564
  11. 11

    Patient Outcomes From a Specialized Inherited Arrhythmia Clinic.

    Adler A, Sadek MM, Chan AY, et al.

    Circulation. Arrhythmia and electrophysiology 2016; (9(1)):e003440.

    PMID: 26743238
  12. 12

    Drug-induced QT interval prolongation and torsades de pointes: Role of the pharmacist in risk assessment, prevention and management.

    Tisdale JE

    Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC 2016; (149(3)):139-52 doi:10.1177/1715163516641136.

    PMID: 27212965
  13. 13

    Avoiding sports-related sudden cardiac death in children with congenital channelopathy : Recommendations for sports activities.

    Lang CN, Steinfurt J, Odening KE

    Herz 2017; (42(2)):162-170 doi:10.1007/s00059-017-4549-2.

    PMID: 28233036
  14. 14

    The new kids on the block of arrhythmogenic disorders: Short QT syndrome and early repolarization.

    Mazzanti A, Underwood K, Nevelev D, et al.

    Journal of cardiovascular electrophysiology 2017; (28(10)):1226-1236 doi:10.1111/jce.13265.

    PMID: 28569435
  15. 15

    In silico investigation of a KCNQ1 mutation associated with short QT syndrome.

    Adeniran I, Whittaker DG, El Harchi A, et al.

    Scientific reports 2017; (7(1)):8469 doi:10.1038/s41598-017-08367-2.

    PMID: 28814790
  16. 16

    Impact of QTc formulae in the prevalence of short corrected QT interval and impact on probability and diagnosis of short QT syndrome.

    Providência R, Karim N, Srinivasan N, et al.

    Heart (British Cardiac Society) 2018; (104(6)):502-508 doi:10.1136/heartjnl-2017-311673.

    PMID: 28954836
  17. 17

    Multiple clinical profiles of families with the short QT syndrome.

    Akdis D, Saguner AM, Medeiros-Domingo A, et al.

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2018; (20(FI1)):f113-f121 doi:10.1093/europace/eux186.

    PMID: 29016797
  18. 18

    Pro-arrhythmogenic Effects of the V141M KCNQ1 Mutation in Short QT Syndrome and Its Potential Therapeutic Targets: Insights from Modeling.

    Lee HC, Rudy Y, Liang H, et al.

    Journal of medical and biological engineering 2017; (37(5)):780-789 doi:10.1007/s40846-017-0257-x.

    PMID: 29213224
  19. 19

    Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome.

    Mazzanti A, Maragna R, Vacanti G, et al.

    Journal of the American College of Cardiology 2017; (70(24)):3010-3015 doi:10.1016/j.jacc.2017.10.025.

    PMID: 29241489
  20. 20

    Hypothetical "anatomy" of Brugada phenomenon: "Long QT sine Long QT" syndrome implicating morphologically undefined specific "Brugada's myocells".

    Stirbys P

    Journal of atrial fibrillation 2017; (9(6)):1554 doi:10.4022/jafib.1554.

    PMID: 29250293
  21. 21

    Genetic basis of channelopathies and cardiomyopathies in Hong Kong Chinese patients: a 10-year regional laboratory experience.

    Mak CM, Chen SP, Mok NS, et al.

    Hong Kong medical journal = Xianggang yi xue za zhi 2018; (24(4)):340-349 doi:10.12809/hkmj176870.

    PMID: 29497013
  22. 22

    Diagnosis and management of short QT syndrome.

    Bjerregaard P

    Heart rhythm 2018; (15(8)):1261-1267 doi:10.1016/j.hrthm.2018.02.034.

    PMID: 29501667
  23. 23

    [Recognizing rare cardiac diseases by electrocardiogram].

    Grimm W, Grimm A, Grimm K, Efimova E

    Der Internist 2018; (59(6)):618-629 doi:10.1007/s00108-018-0400-y.

    PMID: 29619572
  24. 24

    Inherited primary arrhythmia disorders: cardiac channelopathies and sports activity.

    Marrakchi S, Kammoun I, Bennour E, et al.

    Herz 2020; (45(2)):142-157 doi:10.1007/s00059-018-4706-2.

    PMID: 29744527
  25. 25

    Clinical Spectrum of SCN5A Mutations: Long QT Syndrome, Brugada Syndrome, and Cardiomyopathy.

    Wilde AAM, Amin AS

    JACC. Clinical electrophysiology 2018; (4(5)):569-579 doi:10.1016/j.jacep.2018.03.006.

    PMID: 29798782
  26. 26

    Anxiety in children attending a specialist inherited cardiac arrhythmia clinic: a questionnaire study.

    Last AN, English J, Pote H, et al.

    BMJ paediatrics open 2018; (2(1)):e000271 doi:10.1136/bmjpo-2018-000271.

    PMID: 30234175
  27. 27

    Human Atrial Arrhythmogenesis and Sinus Bradycardia in KCNQ1-Linked Short QT Syndrome: Insights From Computational Modelling.

    Whittaker DG, Colman MA, Ni H, et al.

    Frontiers in physiology 2018; (9()):1402 doi:10.3389/fphys.2018.01402.

    PMID: 30337886
  28. 28

    Transgenic short-QT syndrome 1 rabbits mimic the human disease phenotype with QT/action potential duration shortening in the atria and ventricles and increased ventricular tachycardia/ventricular fibrillation inducibility.

    Odening KE, Bodi I, Franke G, et al.

    European heart journal 2019; (40(10)):842-853 doi:10.1093/eurheartj/ehy761.

    PMID: 30496390
  29. 29

    Severe hypercalcemia from multiple myeloma as an acquired cause of short QT.

    Liu Y, Pérez-Riera AR, Barbosa-Barros R, et al.

    Journal of electrocardiology 2018; (51(6)):939-940 doi:10.1016/j.jelectrocard.2018.07.020.

    PMID: 30497751
  30. 30

    Implantable cardioverter defibrillator replacement guided by T wave safety margin in a short QT syndrome patient.

    Shen Y, Pan W, Jiang C, et al.

    Pacing and clinical electrophysiology : PACE 2019; (42(5)):557-559 doi:10.1111/pace.13580.

    PMID: 30548872
  31. 31

    Molecular autopsy: using the discovery of a novel de novo pathogenic variant in the KCNH2 gene to inform healthcare of surviving family.

    Dong J, Williams N, Cerrone M, et al.

    Heliyon 2018; (4(12)):e01015 doi:10.1016/j.heliyon.2018.e01015.

    PMID: 30582040
  32. 32

    Long-term follow-up of implantable cardioverter-defibrillators in Short QT syndrome.

    El-Battrawy I, Besler J, Ansari U, et al.

    Clinical research in cardiology : official journal of the German Cardiac Society 2019; (108(10)):1140-1146 doi:10.1007/s00392-019-01449-3.

    PMID: 30879093
  33. 33

    Acquired short QT syndrome in a cancer patient treated with Toad.

    Huang Y, Xu Y, Barajas-Martinez H, Hu D

    Pacing and clinical electrophysiology : PACE 2019; (42(9)):1273-1275 doi:10.1111/pace.13708.

    PMID: 31037741
  34. 34

    Impact of Antiarrhythmic Drugs on the Outcome of Short QT Syndrome.

    El-Battrawy I, Besler J, Li X, et al.

    Frontiers in pharmacology 2019; (10()):771 doi:10.3389/fphar.2019.00771.

    PMID: 31427960
  35. 35

    How Patient Perceptions Shape Responses and Outcomes in Inherited Cardiac Conditions.

    O'Donovan C, Ingles J, Broadbent E, et al.

    Heart, lung & circulation 2020; (29(4)):641-652 doi:10.1016/j.hlc.2019.11.003.

    PMID: 31974024
  36. 36

    Differences in Short QT Syndrome Subtypes: A Systematic Literature Review and Pooled Analysis.

    Raschwitz LS, El-Battrawy I, Schlentrich K, et al.

    Frontiers in genetics 2019; (10()):1312 doi:10.3389/fgene.2019.01312.

    PMID: 32010184
  37. 37

    [Long and short QT syndromes : Emergency treatment and secondary prophylaxis].

    Horn N, Rüb N, Wolpert C

    Herzschrittmachertherapie & Elektrophysiologie 2020; (31(1)):48-54 doi:10.1007/s00399-020-00666-y.

    PMID: 32025785
  38. 38

    Aborted cardiac arrest during sport activity in a teenager diagnosed with short QT syndrome.

    Ramoğlu MG, Karagözlü S, Uçar T, Tutar E

    Cardiology in the young 2020; (30(6)):886-889 doi:10.1017/S1047951120001055.

    PMID: 32372732
  39. 39

    Inherited cardiac arrhythmias.

    Schwartz PJ, Ackerman MJ, Antzelevitch C, et al.

    Nature reviews. Disease primers 2020; (6(1)):58 doi:10.1038/s41572-020-0188-7.

    PMID: 32678103
  40. 40

    Management of ventricular electrical storm: a contemporary appraisal.

    Kowlgi GN, Cha YM

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2020; (22(12)):1768-1780 doi:10.1093/europace/euaa232.

    PMID: 32984880
  41. 41

    Short QT syndrome: The current evidences of diagnosis and management.

    Dewi IP, Dharmadjati BB

    Journal of arrhythmia 2020; (36(6)):962-966 doi:10.1002/joa3.12439.

    PMID: 33335610
  42. 42

    Long-term prognosis of short QT interval in Korean patients: a multicenter retrospective cohort study.

    Kim DY, Uhm JS, Kim M, et al.

    BMC cardiovascular disorders 2021; (21(1)):17 doi:10.1186/s12872-020-01824-3.

    PMID: 33407155
  43. 43

    Novel electrocardiographic criteria for short QT syndrome in children and adolescents.

    Suzuki H, Horie M, Ozawa J, et al.

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2021; (23(12)):2029-2038 doi:10.1093/europace/euab097.

    PMID: 34179980
  44. 44

    Preclinical short QT syndrome models: studying the phenotype and drug-screening.

    Fan X, Yang G, Kowitz J, et al.

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2022; (24(3)):481-493 doi:10.1093/europace/euab214.

    PMID: 34516623
  45. 45

    Evaluation of gene validity for CPVT and short QT syndrome in sudden arrhythmic death.

    Walsh R, Adler A, Amin AS, et al.

    European heart journal 2022; (43(15)):1500-1510 doi:10.1093/eurheartj/ehab687.

    PMID: 34557911
  46. 46

    Efficacy and tolerability of quinidine as salvage therapy for monomorphic ventricular tachycardia in patients with structural heart disease.

    Deshmukh A, Larson J, Ghannam M, et al.

    Journal of cardiovascular electrophysiology 2021; (32(12)):3173-3178 doi:10.1111/jce.15260.

    PMID: 34586686
  47. 47

    Drug Interactions Affecting Antiarrhythmic Drug Use.

    Mar PL, Horbal P, Chung MK, et al.

    Circulation. Arrhythmia and electrophysiology 2022; (15(5)):e007955 doi:10.1161/CIRCEP.121.007955.

    PMID: 35491871
  48. 48

    CLINICAL CASES OF LIFE-THREATENING ARRHYTHMIAS: LONG AND SHORT QT SYNDROMES.

    Grytsay ON, Skybchyk YV, Shorikova DV, Shorikov EI

    Wiadomosci lekarskie (Warsaw, Poland : 1960) 2022; (75(7)):1805-1812 doi:10.36740/WLek202207113.

    PMID: 35962703
  49. 49

    Incomplete Penetrance and Variable Expressivity: From Clinical Studies to Population Cohorts.

    Kingdom R, Wright CF

    Frontiers in genetics 2022; (13()):920390 doi:10.3389/fgene.2022.920390.

    PMID: 35983412
  50. 50

    Cardiogenetics: the role of genetic testing for inherited arrhythmia syndromes and sudden death.

    Specterman MJ, Behr ER

    Heart (British Cardiac Society) 2023; (109(6)):434-441 doi:10.1136/heartjnl-2021-320015.

    PMID: 36167638
  51. 51

    Supraventricular tachyarrhythmia and sinus node dysfunction as a first manifestation of short QT syndrome in a pediatric patient. Case Report.

    Ploneda-Valencia RG, Ortiz-Solis WA, Ruiz-Gonzalez G, et al.

    Journal of electrocardiology 2022; (74()):146-153 doi:10.1016/j.jelectrocard.2022.08.010.

    PMID: 36240673
  52. 52

    [Asymptomatic channelopathies : Risk stratification and primary prophylaxis].

    Aweimer A, Mügge A, Akin I, El-Battrawy I

    Herzschrittmachertherapie & Elektrophysiologie 2023; (34(2)):101-108 doi:10.1007/s00399-023-00937-4.

    PMID: 37103573
  53. 53

    Human Sinoatrial Node Pacemaker Activity: Role of the Slow Component of the Delayed Rectifier K+ Current, IKs.

    Verkerk AO, Wilders R

    International journal of molecular sciences 2023; (24(8)) doi:10.3390/ijms24087264.

    PMID: 37108427
  54. 54

    Pro-arrhythmic effects of gain-of-function potassium channel mutations in the short QT syndrome.

    Hancox JC, Du CY, Butler A, et al.

    Philosophical transactions of the Royal Society of London. Series B, Biological sciences 2023; (378(1879)):20220165 doi:10.1098/rstb.2022.0165.

    PMID: 37122211
  55. 55

    The safety of sports in children with inherited arrhythmia substrates.

    Katyal A, Li COY, Franciosi S, Sanatani S

    Frontiers in pediatrics 2023; (11()):1151286 doi:10.3389/fped.2023.1151286.

    PMID: 37124180
  56. 56

    Sudden Cardiac Arrest in the Paediatric Population.

    Franciosi S, Abrams DJ, Ingles J, Sanatani S

    CJC pediatric and congenital heart disease 2022; (1(2)):45-59 doi:10.1016/j.cjcpc.2022.02.001.

    PMID: 37969243
  57. 57

    Are disease-specific patient-reported outcomes measures (PROMs) used in cardiogenetics? A systematic review.

    van Pottelberghe S, Kupper N, Scheirlynck E, et al.

    European journal of human genetics : EJHG 2024; (32(6)):607-618 doi:10.1038/s41431-023-01510-w.

    PMID: 38097768
  58. 58

    Catheter Ablation for Channelopathies: When Is Less More?

    Mehta A, Chandiramani R, Ghosh B, et al.

    Journal of clinical medicine 2024; (13(8)) doi:10.3390/jcm13082384.

    PMID: 38673656
  59. 59

    Congenital short QT syndrome: A review focused on electrocardiographic features.

    Pérez-Riera AR, Barbosa-Barros R, da Silva Rocha M, et al.

    Journal of electrocardiology 2024; (85()):87-94 doi:10.1016/j.jelectrocard.2024.04.009.

    PMID: 38714466
  60. 60

    Relevance of accurate QT correction in the assessment of long QT syndrome.

    Kanniainen M, Pukkila T, Aalto-Setälä K, Räsänen E

    Journal of electrocardiology 2024; (87()):153790 doi:10.1016/j.jelectrocard.2024.153790.

    PMID: 39232409
  61. 61

    Cardiac channelopathies in pediatrics: a genetic update.

    Martínez-Barrios E, Campuzano O, Greco A, et al.

    European journal of pediatrics 2024; (183(11)):4635-4640 doi:10.1007/s00431-024-05757-3.

    PMID: 39307882
  62. 62

    Interpreting the actionable clinical role of rare variants associated with short QT syndrome.

    Martínez-Barrios E, Greco A, Cruzalegui J, et al.

    Human genetics 2024; (143(12)):1499-1508 doi:10.1007/s00439-024-02713-x.

    PMID: 39503779
  63. 63

    The Uncommon Phenomenon of Short QT Syndrome: A Scoping Review of the Literature.

    Boulmpou A, Giannopoulos A, Papadopoulos C, et al.

    Journal of personalized medicine 2025; (15(3)) doi:10.3390/jpm15030105.

    PMID: 40137421
  64. 64

    Psychosocial impact of inherited arrhythmia syndromes on anxiety in paediatric patients and their families.

    Babayeva S, Akgül S, Karagöz T, Ertuğrul İ

    Cardiology in the young 2025; (35(8)):1683-1689 doi:10.1017/S1047951125101236.

    PMID: 40747621
  65. 65

    Management of channelopathies in children.

    Krause U

    Herzschrittmachertherapie & Elektrophysiologie 2025; (36(3)):186-191 doi:10.1007/s00399-025-01098-2.

    PMID: 40762707
  66. 66

    Cardiac Channelopathies in the Pediatric Patient: Short QT Syndrome.

    Tan RB, Shah MJ

    Cardiac electrophysiology clinics 2025; (17(4)):645-650 doi:10.1016/j.ccep.2025.07.012.

    PMID: 41206177
  67. 67

    Attitudes toward returning pathogenic KCNQ1 variant and uptake of cascade screening in the Amish.

    Streeten EA, Guan Y, Ryan KA, et al.

    Genetics in medicine open 2025; (3()):103460 doi:10.1016/j.gimo.2025.103460.

    PMID: 41210375
  68. 68

    Exercise practice and short-QT interval on ECG.

    Mascia G, Brugada J, Arbelo E, et al.

    Journal of electrocardiology 2026; (94()):154173 doi:10.1016/j.jelectrocard.2025.154173.

    PMID: 41380380
  69. 69

    Risk stratification in short QT syndrome: Findings from a pooled analysis.

    Giladi M, Solomon A, Viskin D, et al.

    Heart rhythm 2026; (23(9)):e2162-e2166 doi:10.1016/j.hrthm.2026.03.001.

    PMID: 41794082
  70. 70

    Familial Short QT Syndrome: Phenotypic Variability and Challenges in Risk Stratification.

    Bouzón P, Alen A, Salgado M, et al.

    Journal of clinical medicine 2026; (15(9)) doi:10.3390/jcm15093461.

    PMID: 42123196
  71. 71

    Refractory Malignant Arrhythmia in a 4-Year-Old Child With Short QT Syndrome: Persistence for Hope.

    Wang Y, Zuo C, Zeng M, et al.

    JACC. Case reports 2026; (31(24)):108318 doi:10.1016/j.jaccas.2026.108318.

    PMID: 42132729
  72. 72

    Short QT Syndrome With Synonymous RYR2 Variant: A Case Suggesting Intermediate Arrhythmic Risk.

    Comune A, Maddaloni V, Miglio D, et al.

    JACC. Case reports 2026; (31(35)):109218 doi:10.1016/j.jaccas.2026.109218.

    PMID: 42423568
  73. 73

    Short QT Syndrome Masquerading as Lone Atrial Fibrillation: Hidden in Plain Sight.

    Yoo TK, Trujillo-Arvizu L, Kaufman C, et al.

    JACC. Case reports 2026; (31(30)):108675 doi:10.1016/j.jaccas.2026.108675.

    PMID: 42530204
  74. 74

    Successful extravascular implantable cardioverter-defibrillator implantation in a patient with short QT syndrome: A case report.

    Kodera N, Nishii N, Ueoka A, et al.

    Journal of cardiology cases 2026; (34(4)):139-143 doi:10.1016/j.jccase.2026.06.002.

    PMID: 42889605